118 related articles for article (PubMed ID: 20821057)
1. Protective effect of urocortin on 1-methyl-4-phenylpyridinium-induced dopaminergic neuronal death.
Kim Y; Park MK; Chung S
Mol Cells; 2010 Nov; 30(5):427-33. PubMed ID: 20821057
[TBL] [Abstract][Full Text] [Related]
2. Corticotropin-releasing factor (CRF) and related peptides confer neuroprotection via type 1 CRF receptors.
Facci L; Stevens DA; Pangallo M; Franceschini D; Skaper SD; Strijbos PJ
Neuropharmacology; 2003 Oct; 45(5):623-36. PubMed ID: 12941376
[TBL] [Abstract][Full Text] [Related]
3. Urocortin, but not urocortin II, protects cultured hippocampal neurons from oxidative and excitotoxic cell death via corticotropin-releasing hormone receptor type I.
Pedersen WA; Wan R; Zhang P; Mattson MP
J Neurosci; 2002 Jan; 22(2):404-12. PubMed ID: 11784785
[TBL] [Abstract][Full Text] [Related]
4. Urocortin modulates inflammatory response and neurotoxicity induced by microglial activation.
Wang MJ; Lin SZ; Kuo JS; Huang HY; Tzeng SF; Liao CH; Chen DC; Chen WF
J Immunol; 2007 Nov; 179(9):6204-14. PubMed ID: 17947696
[TBL] [Abstract][Full Text] [Related]
5. cAMP- and Ca²(+) /calmodulin-dependent protein kinases mediate inotropic, lusitropic and arrhythmogenic effects of urocortin 2 in mouse ventricular myocytes.
Yang LZ; Kockskämper J; Khan S; Suarez J; Walther S; Doleschal B; Unterer G; Khafaga M; Mächler H; Heinzel FR; Dillmann WH; Pieske B; Spiess J
Br J Pharmacol; 2011 Jan; 162(2):544-56. PubMed ID: 20942811
[TBL] [Abstract][Full Text] [Related]
6. Urocortin 2 stimulates nitric oxide production in ventricular myocytes via Akt- and PKA-mediated phosphorylation of eNOS at serine 1177.
Walther S; Pluteanu F; Renz S; Nikonova Y; Maxwell JT; Yang LZ; Schmidt K; Edwards JN; Wakula P; Groschner K; Maier LS; Spiess J; Blatter LA; Pieske B; Kockskämper J
Am J Physiol Heart Circ Physiol; 2014 Sep; 307(5):H689-700. PubMed ID: 25015964
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor 1 protects human neuroblastoma cells SH-EP1 against MPP+-induced apoptosis by AKT/GSK-3β/JNK signaling.
Wang L; Yang HJ; Xia YY; Feng ZW
Apoptosis; 2010 Dec; 15(12):1470-9. PubMed ID: 20963499
[TBL] [Abstract][Full Text] [Related]
8. Corticotropin releasing factor-induced ERK phosphorylation in AtT20 cells occurs via a cAMP-dependent mechanism requiring EPAC2.
Van Kolen K; Dautzenberg FM; Verstraeten K; Royaux I; De Hoogt R; Gutknecht E; Peeters PJ
Neuropharmacology; 2010 Jan; 58(1):135-44. PubMed ID: 19573542
[TBL] [Abstract][Full Text] [Related]
9. Molecular determinants and feedback circuits regulating type 2 CRH receptor signal integration.
Markovic D; Punn A; Lehnert H; Grammatopoulos DK
Biochim Biophys Acta; 2011 May; 1813(5):896-907. PubMed ID: 21338628
[TBL] [Abstract][Full Text] [Related]
10. Urocortin modulates dopaminergic neuronal survival via inhibition of glycogen synthase kinase-3β and histone deacetylase.
Huang HY; Lin SZ; Chen WF; Li KW; Kuo JS; Wang MJ
Neurobiol Aging; 2011 Sep; 32(9):1662-77. PubMed ID: 19875195
[TBL] [Abstract][Full Text] [Related]
11. The Neuroprotective Role of Insulin Against MPP(+) -Induced Parkinson's Disease in Differentiated SH-SY5Y Cells.
Ramalingam M; Kim SJ
J Cell Biochem; 2016 Apr; 117(4):917-26. PubMed ID: 26364587
[TBL] [Abstract][Full Text] [Related]
12. Corticotropin-releasing factor and urocortin I activate CREB through functionally selective Gβγ signaling in hippocampal pyramidal neurons.
Stern CM; Meitzen J; Mermelstein PG
Eur J Neurosci; 2011 Sep; 34(5):671-81. PubMed ID: 21819464
[TBL] [Abstract][Full Text] [Related]
13. Urocortin-induced decrease in Ca2+ sensitivity of contraction in mouse tail arteries is attributable to cAMP-dependent dephosphorylation of MYPT1 and activation of myosin light chain phosphatase.
Lubomirov LT; Reimann K; Metzler D; Hasse V; Stehle R; Ito M; Hartshorne DJ; Gagov H; Pfitzer G; Schubert R
Circ Res; 2006 May; 98(9):1159-67. PubMed ID: 16574904
[TBL] [Abstract][Full Text] [Related]
14. Desensitization of human CRF2(a) receptor signaling governed by agonist potency and βarrestin2 recruitment.
Hauger RL; Olivares-Reyes JA; Braun S; Hernandez-Aranda J; Hudson CC; Gutknecht E; Dautzenberg FM; Oakley RH
Regul Pept; 2013 Sep; 186():62-76. PubMed ID: 23820308
[TBL] [Abstract][Full Text] [Related]
15. Vasodilative effects of urocortin II via protein kinase A and a mitogen-activated protein kinase in rat thoracic aorta.
Kageyama K; Furukawa K; Miki I; Terui K; Motomura S; Suda T
J Cardiovasc Pharmacol; 2003 Oct; 42(4):561-5. PubMed ID: 14508243
[TBL] [Abstract][Full Text] [Related]
16. The CRF-like peptide urocortin greatly attenuates loss of extracellular striatal dopamine in rat models of Parkinson's disease by activating CRF(1) receptors.
Abuirmeileh A; Harkavyi A; Kingsbury A; Lever R; Whitton PS
Eur J Pharmacol; 2009 Feb; 604(1-3):45-50. PubMed ID: 19026631
[TBL] [Abstract][Full Text] [Related]
17. Involvment of cytosolic and mitochondrial GSK-3beta in mitochondrial dysfunction and neuronal cell death of MPTP/MPP-treated neurons.
Petit-Paitel A; Brau F; Cazareth J; Chabry J
PLoS One; 2009; 4(5):e5491. PubMed ID: 19430525
[TBL] [Abstract][Full Text] [Related]
18. Methylpyridinium (MPP(+))- and nerve growth factor-induced changes in pro- and anti-apoptotic signaling pathways in SH-SY5Y neuroblastoma cells.
Halvorsen EM; Dennis J; Keeney P; Sturgill TW; Tuttle JB; Bennett JB
Brain Res; 2002 Oct; 952(1):98-110. PubMed ID: 12363409
[TBL] [Abstract][Full Text] [Related]
19. Regulation of autophagy by extracellular signal-regulated protein kinases during 1-methyl-4-phenylpyridinium-induced cell death.
Zhu JH; Horbinski C; Guo F; Watkins S; Uchiyama Y; Chu CT
Am J Pathol; 2007 Jan; 170(1):75-86. PubMed ID: 17200184
[TBL] [Abstract][Full Text] [Related]
20. Urocortin attenuates myocardial fibrosis in diabetic rats via the Akt/GSK-3β signaling pathway.
Liu X; Liu C; Li J; Zhang X; Song F; Xu J
Endocr Res; 2016 May; 41(2):148-57. PubMed ID: 26934363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
